Pitt Reasearches Discover Test for Early Ovarian Cancer Detection

According to the Pittsburgh Tribune Review, researchers at the University of Pittsburgh have discovered a new method to detect ovarian cancer in it's early stages. The new method would look for protiens in the patient's blood, and would be much less invasive than the current methods that incorporate biopsies. Most women diagnosed with ovarian cancer live only three or four years because the disease is advanced by the time it is detected.

The new method could detect the presence of "markers" that would alert doctors to the presence of early stage ovarian cancer.
According to the researchers, a single drop of blood from a patient could detect cancer about 98% of the time.

Pittsburgh's medical research community once again proves that it is leading the way with real-world solutions to medical problems. In a post last week, I wrote that Pitt medical researchers are testing a vaccine for juvenile diabetes.
These discoveries are major developments in the medicine, and may save the life of someone you love. The world owes a debt of gratitude to these hard working women and men.

Read More at The Pittsburgh Tribune Review